We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

137 hedge funds and large institutions have $843M invested in Amedisys in 2014 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 37 increasing their positions, 55 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more call options, than puts

Call options by funds: $7.45M | Put options by funds: $2.82M

93% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 15

39% more capital invested

Capital invested by funds: $606M → $843M (+$237M)

10% more funds holding

Funds holding: 125137 (+12)

33% less repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 55

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
137
Holders Change
+12
Holders Change %
+9.6%
% of All Funds
3.65%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
29
Increased
37
Reduced
55
Closed
15
Calls
$7.45M
Puts
$2.82M
Net Calls
+$4.63M
Net Calls Change
+$1.22M
Name Holding Trade Value Shares
Change
Change in
Stake
SFM
26
Systematic Financial Management
New Jersey
$5.1M -$20.4K -825 -0.5%
BCM
27
Bridgeway Capital Management
Texas
$4.92M -$1.64M -66,300 -28%
Charles Schwab
28
Charles Schwab
California
$4.77M -$278K -11,271 -6%
Ameriprise
29
Ameriprise
Minnesota
$4.47M +$158K +6,411 +4%
Morgan Stanley
30
Morgan Stanley
New York
$4.08M +$2.79M +112,807 +432%
Two Sigma Advisers
31
Two Sigma Advisers
New York
$3.3M +$242K +9,800 +10%
CIBC World Market
32
CIBC World Market
Ontario, Canada
$3.2M +$518K +20,971 +24%
BIM
33
BlackRock Investment Management
Delaware
$3.17M -$41K -1,662 -2%
Wells Fargo
34
Wells Fargo
California
$2.85M -$995K -40,281 -29%
Two Sigma Investments
35
Two Sigma Investments
New York
$2.8M -$1.27M -51,345 -35%
SGH
36
Sivik Global Healthcare
Connecticut
$2.79M -$119K -4,800 -5%
CS
37
Credit Suisse
Switzerland
$2.45M +$2.81K +114 +0.1%
SDIC
38
South Dakota Investment Council
South Dakota
$2.24M
Citadel Advisors
39
Citadel Advisors
Florida
$2.19M +$1.84M +74,505 New
Prudential Financial
40
Prudential Financial
New Jersey
$2.13M +$37K +1,500 +2%
New York State Teachers Retirement System (NYSTRS)
41
New York State Teachers Retirement System (NYSTRS)
New York
$2.11M
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$2.1M -$745K -30,184 -30%
TA
43
Teachers Advisors
New York
$1.93M
BC
44
Burney Company
Virginia
$1.93M -$53K -2,148 -3%
Comerica Bank
45
Comerica Bank
Texas
$1.9M +$793K +32,133 +99%
Public Sector Pension Investment Board (PSP Investments)
46
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.84M +$22.2K +900 +1%
RFC
47
Russell Frank Company
Washington
$1.53M -$290K -11,748 -18%
UBS Group
48
UBS Group
Switzerland
$1.53M +$1.29M +52,182 New
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$1.49M +$5.33K +216 +0.4%
EI
50
EAM Investors
California
$1.46M -$148 -6 -0%

AMED Hedge Fund Activity: Q4 2014 in Review

137 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2014, worth a combined $843M — up 39% from $606M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new AMED positions and 15 closed out — a net gain of 14 holders — while 37 added to existing stakes and 55 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $10.5M. The largest seller was JHL Capital Group, exiting entirely with an estimated $18.3M sold.

  • 137 institutional investors held Amedisys (AMED) as of Q4 2014, up from 125 in Q3 2014.
  • Funds reported $843M of Amedisys stock for Q4 2014, up 39% quarter-over-quarter.
  • 29 funds opened new Amedisys positions in Q4 2014 and 15 closed out, a net change of +14 holders.
  • The largest Amedisys buyer in Q4 2014 was D.E. Shaw & Co, an estimated $10.5M added.
  • The largest Amedisys seller in Q4 2014 was JHL Capital Group, an estimated $18.3M sold.

Based on aggregated 13F filings for Q4 2014.